======= SLC25A38 =======
== Gene Information ==
* **Official Symbol**: SLC25A38
* **Official Name**: solute carrier family 25 member 38
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54977|54977]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96DW6|Q96DW6]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SLC25A38&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC25A38|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/610819|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene is a member of the mitochondrial carrier family. The encoded protein is required during erythropoiesis and is important for the biosynthesis of heme. Mutations in this gene are the cause of autosomal congenital sideroblastic anemia (anemia, sideroblastic, 2, pyridoxine-refractory). A related pseudogene is found on chromosome 1. [provided by RefSeq, Aug 2017].
* **UniProt Summary**: Mitochondrial glycine transporter that imports glycine into the mitochondrial matrix. Plays an important role in providing glycine for the first enzymatic step in heme biosynthesis, the condensation of glycine with succinyl-CoA to produce 5-aminolevulinate (ALA) in the mitochondrial matrix. Required during erythropoiesis. {ECO:0000255|HAMAP-Rule:MF_03064, ECO:0000269|PubMed:19412178, ECO:0000269|PubMed:27476175}.
|Mito carr|
|glycine import into mitochondrion|
|glycine transmembrane transporter activity|
|glycine transport|
|amino acid import|
|heme biosynthetic process|
|porphyrin-containing compound biosynthetic process|
|tetrapyrrole biosynthetic process|
|heme metabolic process|
|neutral amino acid transport|
|porphyrin-containing compound metabolic process|
|L-alpha-amino acid transmembrane transport|
|pigment biosynthetic process|
|L-amino acid transport|
|tetrapyrrole metabolic process|
|pigment metabolic process|
|drug transmembrane transport|
|amino acid transmembrane transport|
|erythrocyte differentiation|
|erythrocyte homeostasis|
|mitochondrial transmembrane transport|
|myeloid cell homeostasis|
|amino acid transport|
|carboxylic acid transmembrane transport|
|organic acid transmembrane transport|
|drug transport|
|neurotransmitter transport|
|homeostasis of number of cells|
|cofactor biosynthetic process|
|mitochondrial transport|
|myeloid cell differentiation|
|anion transmembrane transport|
|organic acid transport|
|carboxylic acid transport|
|mitochondrial inner membrane|
|cofactor metabolic process|
|organic anion transport|
|hemopoiesis|
|anion transport|
|hematopoietic or lymphoid organ development|
|cation transmembrane transport|
|immune system development|
|cation transport|
|ion transmembrane transport|
|response to drug|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|mitochondrion|
|transmembrane transport|
|organic cyclic compound biosynthetic process|
|ion transport|
|organonitrogen compound biosynthetic process|
|cellular nitrogen compound biosynthetic process|
|homeostatic process|
|nitrogen compound transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp450|Artemisinin 50μM R08 exp450]]|1.91|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 12815
* **Expression level (log2 read counts)**: 5.29
{{:chemogenomics:nalm6 dist.png?nolink |}}